Lipid nanoparticles in anti-breast cancer drug delivery systems and drug-membrane interactions
Current anticancer drugs are plagued with lack of sustained effect and poor delivery. Many current studies focus on the use of drug carriers, particularly lipid nanoparticles as new drug delivery systems. In this study, a nanostructured lipid carrier (NLC) was formulated to serve as a carrier...
Main Author: | How, Chee Wun |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2014
|
Online Access: | http://psasir.upm.edu.my/id/eprint/70806/1/FPV%202014%2012%20-%20IR.pdf |
Similar Items
-
Editorial: Anti-cancer drug delivery: lipid-based nanoparticles
by: Alaaldin M. Alkilany, et al.
Published: (2023-07-01) -
Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loade nanostructured lipid carriers
by: Beh, Chaw Yee, et al.
Published: (2017) -
Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity
by: How, Chee Wun, et al.
Published: (2013) -
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
by: Yang Hao, et al.
Published: (2023-08-01) -
Lipid-coated polymeric nanoparticles for cancer drug delivery
by: Krishnamurthy, Sangeetha, et al.
Published: (2015)